1. Home
  2. ASIX vs ZYME Comparison

ASIX vs ZYME Comparison

Compare ASIX & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASIX
  • ZYME
  • Stock Information
  • Founded
  • ASIX 2016
  • ZYME 2003
  • Country
  • ASIX United States
  • ZYME United States
  • Employees
  • ASIX N/A
  • ZYME N/A
  • Industry
  • ASIX Major Chemicals
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASIX Industrials
  • ZYME Health Care
  • Exchange
  • ASIX Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • ASIX 663.1M
  • ZYME 761.2M
  • IPO Year
  • ASIX N/A
  • ZYME 2017
  • Fundamental
  • Price
  • ASIX $19.95
  • ZYME $11.53
  • Analyst Decision
  • ASIX Buy
  • ZYME Buy
  • Analyst Count
  • ASIX 2
  • ZYME 6
  • Target Price
  • ASIX $33.00
  • ZYME $19.50
  • AVG Volume (30 Days)
  • ASIX 214.3K
  • ZYME 833.8K
  • Earning Date
  • ASIX 05-02-2025
  • ZYME 05-08-2025
  • Dividend Yield
  • ASIX 3.21%
  • ZYME N/A
  • EPS Growth
  • ASIX N/A
  • ZYME N/A
  • EPS
  • ASIX 1.62
  • ZYME N/A
  • Revenue
  • ASIX $1,517,557,000.00
  • ZYME $76,304,000.00
  • Revenue This Year
  • ASIX $6.16
  • ZYME $26.29
  • Revenue Next Year
  • ASIX $6.27
  • ZYME $75.78
  • P/E Ratio
  • ASIX $12.31
  • ZYME N/A
  • Revenue Growth
  • ASIX N/A
  • ZYME 0.38
  • 52 Week Low
  • ASIX $18.44
  • ZYME $7.97
  • 52 Week High
  • ASIX $33.00
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • ASIX 34.34
  • ZYME 49.31
  • Support Level
  • ASIX $19.66
  • ZYME $10.69
  • Resistance Level
  • ASIX $20.88
  • ZYME $11.48
  • Average True Range (ATR)
  • ASIX 1.09
  • ZYME 0.78
  • MACD
  • ASIX 0.12
  • ZYME 0.10
  • Stochastic Oscillator
  • ASIX 34.55
  • ZYME 81.57

About ASIX AdvanSix Inc.

AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: